Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa2 Slides: 6 Download presentation Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2 a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection Patrick Marcellin, Curtis Cooper, Luis Balart, Dominique Larrey, Terry Box, Eric Yoshida, Eric Lawitz, Peter Buggisch, Peter Ferenci, Martin Weltman, Emily Labriola–Tompkins, Sophie Le Pogam, Isabel Nájera, Denise Thomas, Gregory Hooper, Nancy S. Shulman, Ying Zhang, Mercidita T. Navarro, Chin Yin Lim, Michael Brunda, Norah A. Terrault, Ellen S. Yetzer Gastroenterology Volume 145 Issue 4 Pages 790 -800. e 3 (October 2013) DOI: 10. 1053/j. gastro. 2013. 06. 051 Copyright © 2013 AGA Institute Terms and Conditions Figure 1 Gastroenterology 2013 145790 -800. e 3 DOI: (10. 1053/j. gastro. 2013. 06. 051) Copyright © 2013 AGA Institute Terms and Conditions Figure 2 Gastroenterology 2013 145790 -800. e 3 DOI: (10. 1053/j. gastro. 2013. 06. 051) Copyright © 2013 AGA Institute Terms and Conditions Figure 3 Gastroenterology 2013 145790 -800. e 3 DOI: (10. 1053/j. gastro. 2013. 06. 051) Copyright © 2013 AGA Institute Terms and Conditions Figure 4 Gastroenterology 2013 145790 -800. e 3 DOI: (10. 1053/j. gastro. 2013. 06. 051) Copyright © 2013 AGA Institute Terms and Conditions Supplementary Figure 1 Gastroenterology 2013 145790 -800. e 3 DOI: (10. 1053/j. gastro. 2013. 06. 051) Copyright © 2013 AGA Institute Terms and Conditions Advantage of randomized controlled trialBetaseroneThe first trial of a controlled experiment allowsKambr ordowik sylur dewon karbon perm trias jura kredaPlus j'apprends plus je me rends compte de mon ignorancePlus haut plus loin que l'azur infiniJe contiens du sucre sans être sucré. que suis-je